4
Changes in Ownership
Amylyx Pharmaceuticals, Inc. Filed Acc 0000950170-24-106910
Chief Financial Officer bought 40,000 shares at $2.53 ($101,368)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| FRATES JAMES M Chief Financial Officer | 2024-09-12 | Purchase | +40,000 | $2.53 | $101,368 | 233,464 | D |
| Open-market purchases · 40,000 sh · avg $2.53 · $101,368 | |||||||
Loading xslF345X05/ownership.xml…